Related Experiment Video
Updated: Jul 7, 2026
08:24
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
Yeast as a model for studying human neurodegenerative disorders
Leonor Miller-Fleming1, Flaviano Giorgini, Tiago F Outeiro
1Instituto de Medicina Molecular, Cellular and Molecular Neuroscience Unit, Instituto de Fisiologia, Facultade [corrected] de Medicina da Universidade de Lisboa, Lisboa, Portugal.
Biotechnology Journal
|January 30, 2008
Summary
Budding yeast (Saccharomyces cerevisiae) models neurodegenerative diseases, revealing protein homeostasis roles in pathogenesis. Yeast research identifies therapeutic targets and drugs for brain disorders.
Area of Science:
- Molecular Medicine
- Neurodegenerative Diseases
- Protein Homeostasis
Background:
- Protein misfolding and aggregation are implicated in neurodegenerative diseases.
- The precise molecular mechanisms underlying these pathologies remain unclear.
- Alterations in protein homeostasis are suspected contributors to disease pathogenesis.
Purpose of the Study:
- To review the use of yeast models for studying human neurodegenerative diseases.
- To highlight how yeast models aid in understanding disease mechanisms.
- To explore novel therapeutic approaches derived from yeast-based research.
Main Methods:
- Utilizing Saccharomyces cerevisiae as a model organism for human diseases.
- Replicating key disease features like protein aggregates, cellular toxicity, oxidative stress, and apoptosis in yeast.
- Employing yeast for genetic and compound screens to identify therapeutic targets and drugs.
Main Results:
- Yeast models successfully recapitulate hallmarks of human neurodegenerative diseases.
- This approach has identified potential therapeutic targets and drugs.
- Yeast facilitates rapid screening for therapeutic interventions.
Conclusions:
- Budding yeast is a powerful model system for unraveling neurodegenerative disease mechanisms.
- Yeast-based research provides valuable insights into novel therapeutic strategies.
- Modeling human brain disorders in yeast accelerates the discovery of treatments.
